🧫

Parkinson's Disease Subtype Classification — Precision Medicine Approach

active
experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-pd-disea
🧫 Experiment Protocol Clinicalproposed
SUMMARY
# Parkinson's Disease Subtype Classification — Precision Medicine Approach ## Background and Rationale Parkinson's disease (PD) presents with remarkable clinical and biological heterogeneity, yet current diagnostic and therapeutic approaches treat it as a uniform condition. This heterogeneity manifests in variable motor and non-motor symptoms, differential rates of progression, and inconsistent treatment responses across patients. Recent advances in multi-omics technologies, neuroimaging, and di
METHODOLOGY NOTES
Phase 1 (Months 1-6): Recruit 800 participants including 600 PD patients (300 newly diagnosed, 300 established) and 200 age-matched controls from 10 movement disorder centers. Inclusion criteria: clinical PD diagnosis per MDS criteria, age 50-80, Hoehn-Yahr stages 1-3. Exclusion criteria: atypical parkinsonism, dementia (MoCA <24), significant comorbidities. Phase 2 (Months 3-18): Comprehensive baseline assessment including MDS-UPDRS motor and non-motor evaluations, cognitive testing battery (MoCA, detailed neuropsychological assessment), DaTscan SPECT imaging, 3T MRI with structural, diffusion tensor, and resting-state functional sequences, collection of blood and CSF samples for multi-omics analysis, and deployment of wearable devices (smartwatch, smartphone) for 2-week continuous monitoring periods. Phase 3 (Months 6-24): Process biological samples using standardized protocols for proteomics (TMT mass spectrometry), metabolomics (LC-MS/MS), and transcriptomics (RNA-seq). Analyze d
Metadatasource: {'type': 'manual', 'source_name': 'wiki'
source{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.901397Z'}
summary# Parkinson's Disease Subtype Classification — Precision Medicine Approach ## Background and Rationale Parkinson's disease (PD) presents with remarkable clinical and biological heterogeneity, yet curr
entities{'genes': ['CLDN1/DNMT1/DRD2'], 'diseases': ["Parkinson's Disease"]}
model_systemhuman
_schema_version1
experiment_typeclinical
primary_outcomeValidate Parkinson's Disease Subtype Classification — Precision Medicine Approach
methodology_notesPhase 1 (Months 1-6): Recruit 800 participants including 600 PD patients (300 newly diagnosed, 300 established) and 200 age-matched controls from 10 movement disorder centers. Inclusion criteria: clin
replication_statussingle_study
extraction_metadata{'backfill_at': '2026-04-16T01:00:16.901402', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
735
Outgoing
660
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.